December 1, 2017 Regulatory InDex Pharmaceuticals reports new mechanism of action data for cobitolimod Read more
November 17, 2017 Regulatory InDex Pharmaceuticals Holding AB (publ) interim report January – September 2017 Read more
August 25, 2017 Regulatory InDex Pharmaceuticals Holding AB (publ) interim report January – June 2017 Read more
June 21, 2017 Regulatory InDex Pharmaceuticals enrolls first patient in the phase IIb study CONDUCT with cobitolimod Read more
May 30, 2017 Regulatory Bulletin from Annual General Meeting in InDex Pharmaceuticals Holding AB (publ) Read more
May 30, 2017 Regulatory InDex Pharmaceuticals Holding AB (publ) interim report January – March 2017 Read more
April 27, 2017 Regulatory Notice of Annual General Meeting in InDex Pharmaceuticals Holding AB (publ) Read more
April 27, 2017 Regulatory InDex Pharmaceuticals Holding AB (publ) publishes Annual Report for 2016 Read more
March 14, 2017 Regulatory InDex Pharmaceuticals gets patent for additional DIMS compounds granted in the US Read more
February 1, 2017 Regulatory InDex Pharmaceuticals enters agreement with CRO for the CONDUCT study Read more